Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method

Irene V. Bijnsdorp*, Olga Maxouri, Aarzo Kardar, Tim Schelfhorst, Sander R. Piersma, Thang V. Pham, Andre Vis, R. Jeroen Van Moorselaar, Connie R. Jimenez

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Extracellular vesicles (EVs) secreted by prostate cancer (PCa) cells contain specific biomarkers and can be isolated from urine. Collection of urine is not invasive, and therefore urinary EVs represent a liquid biopsy for diagnostic and prognostic testing for PCa. In this study, we optimised urinary EV isolation using a method based on heat shock proteins and compared it to gold-standard ultracentrifugation. The urinary EV isolation protocol using the Vn96-peptide is easier, time convenient (≈1.5 h) and no special equipment is needed, in contrast to ultracentrifugation protocol (>3.5 h), making this protocol clinically feasible. We compared the isolated vesicles of both ultracentrifugation and Vn96-peptide by proteome profiling using mass spectrometry-based proteomics (n = 4 per method). We reached a depth of >3000 proteins, with 2400 proteins that were commonly detected in urinary EVs from different donors. We show a large overlap (>85%) between proteins identified in EVs isolated by ultracentrifugation and Vn96-peptide. Addition of the detergent NP40 to Vn96-peptide EV isolations reduced levels of background proteins and highly increased the levels of the EV-markers TSG101 and PDCD6IP, indicative of an increased EV yield. Thus, the Vn96-peptide-based EV isolation procedure is clinically feasibly and allows largescale protein profiling of urinary EV biomarkers.

Original languageEnglish
Article number1313091
JournalJournal of Extracellular Vesicles
Issue number1
Publication statusPublished - 2017

Cite this